Business Expenses. During the Term, the Company shall reimburse Executive for all reasonable travel and other business expenses incurred by Executive in the performance of Executive’s duties to the Company in accordance with the Company’s expense reimbursement Policy.
Merus N.V. (MRUS) (CIK 0001651311)
Source: SEC EDGAR database • Date: March 16, 2020 • SIC: 2834 • CIK: 2834
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: August 6, 2019 • SIC: 2834 • CIK: 2834
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: March 2, 2021 • SIC: 2834 • CIK: 2834
Lyra Therapeutics, Inc. (LYRA) (CIK 0001327273)
Source: SEC EDGAR database • Date: March 9, 2022 • SIC: 3841 • CIK: 3841
Homology Medicines, Inc. (FIXX) (CIK 0001661998)
Source: SEC EDGAR database • Date: March 12, 2019 • SIC: 2834 • CIK: 2834
Atea Pharmaceuticals, Inc. (AVIR) (CIK 0001593899)
Source: SEC EDGAR database • Date: March 30, 2021 • SIC: 2834 • CIK: 2834
LogMeIn, Inc. (LOGM) (CIK 0001420302)
Source: SEC EDGAR database • Date: February 14, 2020 • SIC: 7372 • CIK: 7372
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: November 9, 2020 • SIC: 2834 • CIK: 2834
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: November 5, 2019 • SIC: 2834 • CIK: 2834